Edoardo Cignoli : India Cancels Patent on Glaxo Cancer Drug

India has revoked a patent on a Glaxo breast-cancer drug, Tykerb, in the latest blow to Western drug makers trying to sell in this fast-growing market.



via WSJ.com: US Business http://online.wsj.com/article/SB10001424127887324635904578644100746473088.html?mod=pls_whats_news_us_business_f